Clinical Trials on Dermatology in New Zealand

Total 7 results

Celgene

No longer available

Expanded Access for CC-2001

Other | Dermatologic

United States
Sight Diagnostics

Completed

Analytical and Clinical Performance Testing Plan

Hematology | Hematologic Test

United States
Memorial Sloan Kettering Cancer Center
Comprehensive Cancer Centre The Netherlands

Recruiting

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Cancer | Dermatologic Conditions

United States
Northwell Health

Terminated

Porcine Xenograft Versus Second Intention Healing

Wound Healing and Scar Quality Following Mohs Surgery and Excisional Dermatologic Surgery

United States
iSpecimen Inc

Enrolling by invitation

Collection and Distribution of Biospecimens for Novel Research

Autoimmune Diseases | Healthy | Cancer | Infectious Disease | Blood Disease | Gastrointestinal Complication | Dermatologic Disease | Women's Health: High-Risk Pregnancy

United States
Amgen

Completed

AMG 319 Lymphoid Malignancy FIH

Lymphoma | Leukemia | Cancer | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Hematologic Malignancies | Diffuse Large Cell Lymphoma | Oncology | Tumors | T Cell Lymphoma | Oncology Patients | Hematology | Low Grade Lymphoma

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Colorectal Cancer | Lung Cancer | Dermatologic Complications | Therapy-related Toxicity

United States

Clinical Trials on Dermatology in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations